CUE - Cue in pact with Boehringer for autoimmune and inflammatory diseases April, 15 2025 08:00 AM Cue Biopharma Inc. 2025-04-15 08:00:13 ET More on Cue Biopharma Cue Biopharma stock falls after pricing capital raise of $20M via securities offering Seeking Alpha’s Quant Rating on Cue Biopharma Historical earnings data for Cue Biopharma Financial information for Cue Biopharma For further details see: Cue in pact with Boehringer for autoimmune and inflammatory diseases